BP-I
Natural health product licensed in Canada
- Licence holder
- Nutragenius Inc.
- NPN or DIN-HM
- 80091017
- Status
- Inactive licence
- Licence date
- 28 February 2019
- Revision date
- Not provided
- Form
- Capsule
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| 3,3',4',5,7-Pentahydroxyflavone Source : Vaccinium myrtillus - Fruit | 160 mg |
| Vaccinium angustifolium Source : Fruit Extraction ratio : 20:1 Dry plant equivalent : 400 mg | 20 mg |
| L-arginine Source : Monohydrochlorure de L-arginine | 50 mg |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : bactéries, levures | 30 mg |
| Coffea arabica L. Source : Fève Potency : 50 % chlorogenic acids | 50 mg |
| Coffea arabica L. Source : Fève Potency : 10 % caffeine | Not specified |
Non-medicinal ingredients
Hypromellose, chlorophylle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine as a capillary/blood vessel protectant. Helps maintain healthy blood pressure levels. Helps to maintain and/or support cardiovascular. Helps to support peripheral circulation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80091017
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.